New biomarker HRG (Histidine-Rich Glycoprotein) that enables early diagnosis and severity assessment of sepsis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1061220024

Enrollment

150

Registered

2022-06-04

Start date

2022-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Inpatients who visited the emergency outpatient department of Okayama University Hospital or a joint research institute between March 31, 2023 after the approval of the Institutional Review Board and met two or more qSOFA criteria 2 Patients who can voluntarily obtain consent to participate in the study in writing from the person or his / her surrogate

Exclusion criteria

Exclusion criteria: 1 Under 18 years old 2 Pregnant woman 3 Patients after resuscitation with cardiopulmonary arrest 4 Patients transferred from another hospital 5 Patients who are considered inappropriate for study for other reasons

Design outcomes

Primary

Measure	Time frame
Clinical performance (sensitivity, specificity) of differential diagnosis of sepsis by HRG	—

Secondary

Measure	Time frame
1 Clinical performance (concordance) of differential diagnosis of sepsis by HRG 2 Relationship between HRG and prognosis	—

Contacts

Public ContactHiroshi Morimatsu

Okayama University Hospital

pb9b45wr@okayama-u.ac.jp+81-86-235-7330

Outcome results